BPG is committed to discovery and dissemination of knowledge
Clinical Trials Study
Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 7, 2026; 32(37): 119668
Published online Oct 7, 2026. doi: 10.3748/wjg.119668
Table 4 Overall summary of adverse events (intention-to-treat set), n (%)
Variable
7-day PC-BMT (n = 119)
14-day PC-BMT (n = 118)
14-day P-BMT (n = 117)
n
Frequency
n
Frequency
n
Frequency
Adverse event23 (19.3)3436 (30.5)5132 (27.4)40
95%CI12.7-27.622.4-39.719.5-36.4
P value0.1450.594
Drug-related adverse event23 (19.3)3435 (29.7)5031 (26.5)39
95%CI12.7-27.621.6-38.818.7-35.5
P value0.1900.589
Serious adverse event0 00 000


Write to the Help Desk